Background: Imaging studies in Alzheimer’s disease (AD) have yet to answer the underlying questions concerning the relationship among tau retention, neuroinflammation, network disruption and cognitive decline. We compared the spatial retention patterns of 18F-THK5351 and resting state network (RSN) disruption in patients with early AD and healthy controls.Methods: We enrolled 23 11C-Pittsburgh compound B (PiB)-positive patients with early AD and 24 11C-PiB-negative participants as healthy controls. All participants underwent resting state functional MRI and 18F-THK5351 PET scans. We used scaled subprofile modeling/principal component analysis (SSM/PCA) to reduce the complexity of multivariate data and to identify patterns that exhibited the...
OBJECTIVE: To investigate the topographical distribution of tau pathology and its effect on function...
Alzheimer’s Disease (AD) and Progressive Supranuclear Palsy (PSP) represent neurodegenerative Tauopa...
Background: The mechanism of synaptic loss in Alzheimer’s disease is poorly understood and may be as...
Background: Imaging studies in Alzheimer’s disease (AD) have yet to answer the underlying questions ...
As a central hub in the interconnected brain network, the precuneus has been reported showing disrup...
PurposePosterior cingulate cortex (PCC) hypometabolism as measured by FDG PET is an indicator of Alz...
Purpose: We aimed to investigate associations between tau pathology and relative cerebral blood flow...
Tau pathology and neuroinflammation are key etio-pathogenetic mediators of Alzheimer’s disease (AD)....
The posteromedial cortex (PMC) is a key region involved in the development and progression of Alzhei...
The interplay among neuropathological mechanisms underlying Alzheimer’s disease (AD), as neuroinflam...
Objective: To investigate the characteristics of tau deposition and its impact on functional connect...
In Alzheimer’s diseases (AD), tau pathology is strongly associated with cognitive decline. Preclinic...
In Alzheimer’s disease (AD), younger symptom onset is associated with accelerated disease progressio...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder which causes dementia, especial...
PURPOSE: The aim of this study was to explore the cerebral distribution of the tau-specific PET trac...
OBJECTIVE: To investigate the topographical distribution of tau pathology and its effect on function...
Alzheimer’s Disease (AD) and Progressive Supranuclear Palsy (PSP) represent neurodegenerative Tauopa...
Background: The mechanism of synaptic loss in Alzheimer’s disease is poorly understood and may be as...
Background: Imaging studies in Alzheimer’s disease (AD) have yet to answer the underlying questions ...
As a central hub in the interconnected brain network, the precuneus has been reported showing disrup...
PurposePosterior cingulate cortex (PCC) hypometabolism as measured by FDG PET is an indicator of Alz...
Purpose: We aimed to investigate associations between tau pathology and relative cerebral blood flow...
Tau pathology and neuroinflammation are key etio-pathogenetic mediators of Alzheimer’s disease (AD)....
The posteromedial cortex (PMC) is a key region involved in the development and progression of Alzhei...
The interplay among neuropathological mechanisms underlying Alzheimer’s disease (AD), as neuroinflam...
Objective: To investigate the characteristics of tau deposition and its impact on functional connect...
In Alzheimer’s diseases (AD), tau pathology is strongly associated with cognitive decline. Preclinic...
In Alzheimer’s disease (AD), younger symptom onset is associated with accelerated disease progressio...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder which causes dementia, especial...
PURPOSE: The aim of this study was to explore the cerebral distribution of the tau-specific PET trac...
OBJECTIVE: To investigate the topographical distribution of tau pathology and its effect on function...
Alzheimer’s Disease (AD) and Progressive Supranuclear Palsy (PSP) represent neurodegenerative Tauopa...
Background: The mechanism of synaptic loss in Alzheimer’s disease is poorly understood and may be as...